1Petaja J, Pitkanen S, Vettenranta K, et al. Serum tumor marker CA 125 is an early and sensitive indicator of veno- occlusive disease in children undergoing bone marrow transplantation[J].Clin Cancer Res, 2000, 6;531-535.
3Richardson PG,Murakami C,Jin Z,et al.Multiinstitutional use of defibrotide in 88 patients after stem cell transplantation with severe veno-occlusive disease and multisystem organ faiinra response without significant toxicity in a high-risk population and factors predictive of outcome[J]. Blood, 2002, 100 (13).. 4337-4343.
3Hill KR,Rhodes K,Stafford JL,et al.Serous hepatosis:a pathogenesis of hepatic fibrosis in Jamaican children.Br Med J,1953,1:117-122.
4Bras G,Hill KR.Veno-occlusive disease of the liver,essential pathology.Lancet,1956,28,271:161-163.
5Jones RJ,Lee KS,Beschorner WE,et al.Venoocclusive disease of the liver following bone marrow transplantation.Transplantation,1987,44:778-783.
6Shulman HM,Hinterberger W.Hepatic veno-occlusive disease-liver toxicity syndrome after bone marrow transplantation(Review).Bone Marrow Transplant,1992,10:197-214.
7Carreras E,Granena A,Rozman C.Hepatic veno-occlusive disease after bone marrow transplant(Review).Blood Rev,1993,7:43-51.
8Griner PF,Elbadawi A,Packman CH.Veno-occlusive disease of the liver after chemotherapy of acute leukemia:report of two cases.Ann Intern Med,1976,85:578-582.
